PBAC's latest decision on Measles mumps rubella varicella priorix tetra gsk: Recommended with restriction (2007). Considered for The combination measles, mumps, rubella and varicella vaccine for children aged 12 months on the NIP.
PBAC outcome
Recommended with restriction
Authority Required
ICER (AUD/QALY)
$45k/QALY
Range: $15k/QALY–$45k/QALY
Submissions
1
first 2007
Submissions
1
2007 → 2007
Eligible population
children aged 12 months on the NIP
Therapy area
Immunology
Evidence base
RCT
Key trials
Trial 038, Trial 043, Trial 044
Comparator
MMR at 12 months and MMR co-administered with VV at 18 months of age